Introduction
============

The ER is responsible for folding and processing proteins entering the secretory pathway and uses a variety of mechanisms to adjust its capacity in response to changes in the folding burden. This collection of mechanisms, termed the unfolded protein response (UPR; [@bib24]), is activated by stress caused by environmental stimuli and diseases such as viral infection ([@bib27]; [@bib2]) and multiple myeloma ([@bib4]). In metazoans, components of the UPR are essential for developmental processes requiring high levels of secretion such as the differentiation of plasma cells ([@bib7]; [@bib14]) and pancreatic β cells ([@bib9]; [@bib30]). The UPR restores ER function both by increasing its capacity and decreasing the load of new proteins through transcriptional induction of secretory pathway components and general translational attenuation. One of the key players in the UPR is Ire1 (inositol-requiring enzyme 1), a conserved transmembrane protein with a luminal domain that senses protein misfolding in the ER. The resulting oligomerization of Ire1 leads to activation of its cytoplasmic kinase and endoribonuclease domain. The main function of the kinase appears to be activation of the nuclease, which requires binding of ATP or ADP in the active site of the kinase ([@bib23]). The nuclease in turn cleaves two specific sites in the mRNA encoding XBP-1 (X-box--binding protein 1), a conserved UPR transcription factor, which leads to XBP-1 activation and translation through removal of a regulatory intron.

We have recently shown that Ire1 in *Drosophila melanogaster* cells independently mediates the cleavage and degradation of mRNAs encoding proteins that traverse the secretory pathway ([@bib11]). This new branch of the UPR, which we call regulated Ire1-dependent decay (RIDD), has the potential to selectively relieve the burden on the ER while clearing the translation and translocation machinery for the subsequent influx of new proteins induced by the UPR. Studies on the regulation of specific messages suggest that the RIDD pathway also operates in mammalian cells ([@bib28]; [@bib15]; [@bib22]; [@bib12]; [@bib21]). Mammals express two isoforms of Ire1: Ire1-α is expressed ubiquitously, and Ire1-β is expressed in intestinal epithelial cells. Overexpression of Ire1-α leads to cleavage of its own message in COS-1 cells ([@bib28]) and reduced levels of the message encoding CD59 (complement defense 59) in HeLa cells ([@bib22]). Ire1-α also appears to mediate the degradation of insulin transcripts in pancreatic β cells under chronic high glucose conditions, perhaps promoting cell survival during extreme chronic stress ([@bib21]). Ire1-β appears to have alternative targets as well, mediating cleavage of the 28-S ribosomal RNA ([@bib15]) and the mRNA encoding microsomal triglyceride transfer protein, an ER chaperone important for the assembly of lipid transport vesicles ([@bib12]). Together, these examples of Ire1 function in mRNA decay may explain observations that Ire1 in metazoans has a broader range of physiological outputs than XBP-1 splicing ([@bib29]).

In this study, we take advantage of mouse fibroblasts lacking Ire1 activity, both to confirm that RIDD is conserved in mammalian cells and to investigate the functional requirements of RIDD. By expressing wild-type and mutant variants of Ire1-α, we find that the nuclease activity of Ire1 is required for both splicing and RIDD. However, these two outputs can be differentially triggered, revealing an unexpected complexity in Ire1 activation.

Results and discussion
======================

Ire1 degrades mRNAs in response to ER stress in mouse fibroblasts
-----------------------------------------------------------------

To determine whether the RIDD pathway functions in mammals as well as in *Drosophila*, we used a mouse embryonic fibroblast (MEF) cell line established by [@bib19] in which the Ire1-α gene has been disrupted. We stably introduced human Ire1-α (hIre1) into these cells using flippase-mediated, site-directed recombination ([@bib5]), which allowed us to insert the wild-type and hIre1 variants discussed in the next sections into the same sites within the genome. In response to various forms of chemically induced ER stress, the reconstituted cells (referred to here as *hIre1^R^*) but not the Ire1 knockout (*Ire1^−/−^*) cells induced the splicing of XBP-1 (see [Fig. 3 B](#fig3){ref-type="fig"}). Both cell lines strongly induced immunoglobin-binding protein (BiP), an abundant ER chaperone, in response to ER stress ([Fig. 1](#fig1){ref-type="fig"}), which is in agreement with previous observations that BiP induction is Ire1 independent in mouse fibroblasts ([@bib19]). As expected, induction of ERdj4, a transcriptional target of the Ire1/XBP-1 branch of the UPR ([@bib18]), was stronger in the *hIre1^R^* cells compared with *Ire1^−/−^* cells, especially in response to DTT, a reducing agent which disrupts disulfide bond formation in the ER ([Fig. 1 A](#fig1){ref-type="fig"}).

![**mRNAs are down-regulated in response to multiple stressors in an Ire1-dependent manner.** (A--C) mRNA abundance for targets of ER stress in *hIre1^R^* and *Ire1^−/−^* cells treated with 2 mM DTT (A), 3 µg/ml Tm (B), or 500 nM thapsigargin (C) for 5 h relative to untreated cells. (D) Relative mRNA abundance in cells lacking functional XBP-1. Cells were untransfected or transfected with negative control siRNA (QIAGEN) or siRNAs targeting Ire1, followed by DTT treatment as in A. (A--D) The means and SDs for three to four independent experiments were measured by qPCR; each sample was normalized using the mRNA levels of Rpl19.](JCB_200903014_GS_Fig1){#fig1}

To investigate the RIDD pathway, we took an unbiased, microarray-based approach. We induced ER stress in the *Ire1^−/−^* and *hIre1^R^* cells with DTT, purified total RNA from treated and untreated cells, amplified and labeled these samples, and hybridized them to whole-genome MEEBOChip arrays. As expected, treatment of our *hIre1^R^* cells with DTT led to the induction of classical UPR targets to levels comparable with that seen by others in wild-type cells ([Fig. S1](http://www.jcb.org/cgi/content/full/jcb.200903014/DC1); [@bib18]).

Consistent with the RIDD pathway functioning in these cells, we observed that several RNAs were down-regulated in response to ER stress in the *hIre1^R^* but not the *Ire1^−/−^* cells ([Fig. 1](#fig1){ref-type="fig"} and Fig. S1). Although ∼120 mRNAs fell into this category in the array data, the magnitudes of the changes in expression were generally small (many were twofold or less) compared with those seen in *Drosophila* cells, where many RNAs were down-regulated by 5--10-fold. Despite the relatively small changes for individual messages, the effect of down-regulating mRNAs at the ER surface may profoundly impact the folding burden of the ER. For example, the redistribution of certain nascent proteins from the ER to the cytosol during ER stress significantly impacts cell survival, although the effect on translocation is similar in magnitude to RIDD ([@bib16]).

To limit false positives, we applied a series of strict criteria for identifying the most likely RIDD targets (see Materials and methods); the results are shown in [Table I](#tbl1){ref-type="table"}. We confirmed the regulation of several of these targets by reverse transcription followed by quantitative real-time PCR (qPCR; [Fig. 1](#fig1){ref-type="fig"} and Fig. S1). To determine whether the down-regulation was a general response to ER stress or was restricted to DTT, we also treated cells with tunicamycin (Tm), which inhibits N-linked glycosylation or thapsigargin, which disrupts calcium homeostasis. All candidate RIDD targets tested were down-regulated in response to these three forms of ER stress in an Ire1-dependent manner ([Fig. 1, A--C](#fig1){ref-type="fig"}).

###### 

Candidate targets of the RIDD pathway in mouse cells

  Target name                                                              UniGene ID   Localization           Mean log~2~ (DTT/untreated)   Decreased stability in DTT   
  ------------------------------------------------------------------------ ------------ ---------------------- ----------------------------- ---------------------------- -----
  Heparan-α-glucosaminide N-acetyltransferase (Hgsnat)                     Mm.28326     Membrane (lysos.)      −1.34                         0.45                         Yes
  Biogenesis of lysosome-related organelles complex-1, subunit 1 (Blos1)   Mm.30118     Cytosol                −1.22                         −0.10                        Yes
  Scavenger receptor class A, member 3 (Scara3)                            Mm.344095    Membrane (ER/Golgi)    −1.11                         0.17                         Yes
  PDGF receptor (Pdgfrb)                                                   Mm.4146      Membrane (PM)          −0.89                         0.12                         Yes
  Peripheral myelin protein (Pmp22)                                        Mm.1237      ECM                    −0.88                         −0.07                        Yes
  Collagen, type VI, α1 (Col6)                                             Mm.2509      ECM                    −0.85                         −0.15                        Yes
  Ephrin B2                                                                Mm.209813    Membrane (PM)          −1.06                         −0.14                        No
  Microtubule-associated protein 7 domain containing 1 (MAP7d1)            Mm.266716    NA                     −0.69                         0.10                         No
  Splicing factor, Arg/Ser rich 3 (SRp20)                                  Mm.6787      Spliceosome            −0.89                         −0.14                        No
  Tripartite motif protein 16 (Trim16)                                     Mm.117087    Cytosol                −0.73                         0.12                         No
  Galnt10                                                                  Mm.271670    Membrane (Golgi)       −0.59                         0.14                         Yes
  Laminin B1 subunit 1                                                     Mm.172674    ECM                    −1.40                         0.08                         ND
  Mannose receptor C type 2                                                Mm.235616    Membrane (PM)          −1.14                         −0.17                        ND
  Leu-rich repeat containing 8C                                            Mm.319847    Membrane               −0.99                         −0.17                        ND
  Neural cell adhesion molecule 1                                          Mm.4974      Membrane (PM)          −0.88                         0.14                         ND
  PDGFA-associated protein 1                                               Mm.188851    ECM                    −0.88                         −0.21                        ND
  Syndecan 4                                                               Mm.3815      Membrane (PM)          −0.85                         −0.18                        ND
  Homeo box B4                                                             Mm.3546      Nucleus                −0.84                         −0.03                        ND
  Expressed sequence C79267                                                Mm.30464     NA                     −0.77                         −0.12                        ND
  3-oxoacid CoA transferase 1                                              Mm.13445     ECM                    −0.77                         −0.02                        ND
  Tripeptidyl peptidase I                                                  Mm.20837     ECM, mitoch., lysos.   −0.74                         −0.12                        ND
  RIKEN cDND 4932417H02                                                    Mm.209933    NA                     −0.71                         0.21                         ND
  Pre--B cell leukemia transcription factor--interacting protein 1         Mm.65906     NA                     −0.69                         0.33                         ND
  Chondroitin sulfate proteoglycan 4 (CSP4)                                Mm.41329     Membrane (PM)          −0.68                         0.28                         ND
  SHANK-associated RH domain--interacting protein                          Mm.41463     Cytosol                −0.67                         0.41                         ND
  ST3 β-galactoside α-2,3-sialyltransferase 5s                             Mm.38248     Membrane (Golgi)       −0.62                         0.17                         ND

lysos., lysosomal; mitoch., mitochondria; NA, not applicable (no annotation available); PM, plasma membrane. Localization data are based on Gene Ontology annotations of the mouse genome. Log~2~ (DTT/untreated) RNA levels were determined by microarray analysis and represent the mean of three independent experiments. Stability data are shown in [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200903014/DC1).

Several observations indicate that the RIDD pathway, if not the specific targets, is conserved in mammalian cells and *Drosophila*. First, the down-regulation of mouse target mRNAs was independent of XBP-1 ([Fig. 1 D](#fig1){ref-type="fig"}). Using RNAi to deplete Ire1 from cells lacking a functional XBP-1 ([@bib18]), we found that Ire1-dependent down-regulation of several target mRNAs occurred in the absence of XBP-1. As a control, in cells lacking XBP-1, ERdj4 was induced only to the level seen in *Ire1^−/−^* cells, and this induction was insensitive to Ire1 depletion ([Fig. 1 D](#fig1){ref-type="fig"}). Second, the down-regulation of many mouse targets was achieved through an increase in their decay rates. We inhibited transcription with actinomycin D and monitored mRNA levels over time in the absence and presence of ER stress ([Fig. 2](#fig2){ref-type="fig"} and [Fig. S2](http://www.jcb.org/cgi/content/full/jcb.200903014/DC1)). For 7 of the 11 targets tested, the decreases in mRNA abundance were dependent not on transcription but on increased rates of mRNA degradation. Third, as in *Drosophila* cells, the set of targets in mouse cells is highly enriched for mRNAs encoding membrane proteins. 17 of the 22 targets in [Table I](#tbl1){ref-type="table"} that were assigned localization annotations in the mouse genome encode membrane or ECM proteins, as do 6 of the 7 confirmed targets that displayed increased decay rates. The seventh confirmed target, Blos1, encodes a protein that does not appear to contain a membrane-spanning domain itself but is part of a complex detected in both cytosolic and peripheral membrane fractions ([@bib26]).

![**mRNAs down-regulated by Ire1 are degraded faster in the presence of ER stress.** *hIre1^R^*, *Ire1^−/−^*, or NIH-3T3 cells were treated with 1 µg/ml actinomycin D and/or 2 mM DTT, and relative mRNA abundance was monitored over time by qPCR. RNA levels were normalized to those of Rpl19 and to untreated controls. Error bars represent the SDs in qPCR replicates; representative time course data from two independent experiments are shown.](JCB_200903014_LW_Fig2){#fig2}

We consistently observed partial splicing of XBP-1 in our *hIre1^R^* cells in the absence of ER stress, which is likely caused by overexpression of hIre1 in these cells. To confirm that the mRNA decay we observed was not an artificial product of additional stress or Ire1 activity caused by overexpression, we measured the mRNA decay rates of two confirmed RIDD targets in NIH-3T3 cells ([Fig. 2](#fig2){ref-type="fig"}). As in our reconstituted cells, NIH-3T3 cells displayed increased decay rates and lower abundance for RIDD targets in the presence of DTT. Collectively, our data indicate that RIDD is a general, conserved pathway associated with folding stress in the ER.

The nuclease activity of Ire1 is required for RIDD
--------------------------------------------------

Because the parent *Ire1^−/−^* cell line lacks Ire1 activity, we could probe specific functions of Ire1 by inserting variants of hIre1 containing point mutations into these cells in an isogenic manner. Using this approach, we expressed an hIre1 variant containing a single point mutation (D847A) that has been previously shown to compromise the nuclease activity of hIre1 while leaving the kinase activity intact ([@bib28]). For these experiments, we used C-terminally Flag-tagged versions of both the wild-type and mutant Ire1 and confirmed by Western blotting that the hIre-D847A variant was expressed at similar levels to the wild type ([Fig. 3 A](#fig3){ref-type="fig"}). Consistent with a lack of nuclease activity, cells expressing hIre1-D847A did not support XBP-1 splicing in the absence or presence of ER stress ([Fig. 3 B](#fig3){ref-type="fig"}) and induced ERdj4 only to the level seen in *Ire1^−/−^* cells ([Fig. 3, C and D](#fig3){ref-type="fig"}). All cell lines induced BiP by similar amounts, indicating that they are experiencing a similar level of ER stress. However, unlike the *Ire1^R^* cells, cells expressing hIre1-D847A displayed no change in the abundance of RIDD targets upon induction of ER stress ([Fig. 3, C and D](#fig3){ref-type="fig"}). These results indicate that the nuclease activity of Ire1 is required for degradation of RIDD targets, which is consistent with a mechanism in which Ire1 directly cleaves these RNAs in response to ER stress.

![**The nuclease activity of Ire1 is required for RIDD.** (A) Western blot of Flag-tagged hIre1 proteins. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. (B) Ethidium bromide--stained agarose gel showing XBP-1 reverse transcribed from total RNA and PCR amplified using primers surrounding the splice site. The asterisk denotes a hybrid band amplified from spliced and unspliced (u) products ([@bib25]). s, spliced product after the removal of the 26 nucleotide intron. Bands were quantified in ImageJ (National Institutes of Health) to determine the percentage of splicing. (C and D) RNA levels of RIDD targets and controls in DTT (C)- and Tm (D)-treated cells measured by qPCR and normalized to signals from Rpl19. (B--D) The means and SDs for three independent experiments are shown.](JCB_200903014_GS_Fig3){#fig3}

Bypassing the kinase activity of Ire1
-------------------------------------

Recently, it has been shown that for yeast and human Ire1, the cytoplasmic kinase activity can be bypassed using a small molecule that binds to the enlarged ATP pocket of an engineered Ire1 variant ([@bib23]; [@bib20]). This variant, I642G in hIre1, has very little activity in the absence of the ATP analogue 1NM-PP1 (4-amino-1-tert-butyl-3-\[1\'-naphthylmethyl\]pyrazolo\[3,4-d\] pyrimidine). Binding allows activation of the nuclease while simultaneously inhibiting the kinase activity of Ire1-I642G. In HEK293 cells ([@bib20]) and MEF cells ([@bib8]), hIre1-I642G splices XBP-1 and induces the UPR upon binding 1NM-PP1 alone, even in the absence of ER stress. To test whether activation of Ire1 is sufficient for degradation of RIDD substrates, we introduced hIre1-I642G into *Ire1^−/−^* cells and tested its activity in the absence and presence of 1NM-PP1 and ER stress ([Fig. 4](#fig4){ref-type="fig"}). Treatment of mouse cells expressing hIre1-I642G with 1NM-PP1 was sufficient to induce splicing of XBP-1 ([Fig. 4 A](#fig4){ref-type="fig"}) and transcriptional induction of the Ire1/XBP-1 target ERdj4 ([Fig. 4 B](#fig4){ref-type="fig"}). This Ire1 activity was not caused by a general induction of ER stress, as cells lacking Ire1 or expressing the wild-type hIre1 were insensitive to 1NM-PP1 ([Fig. 4](#fig4){ref-type="fig"}), although the drug did suppress the Ire1-independent induction of ERdj4 by DTT in all strains through an unknown mechanism ([Fig. 4 B](#fig4){ref-type="fig"}). The 1NM-PP1--induced activation of hIre1-I642G was not caused by increased levels of the protein, as assayed by Western blotting ([Fig. 4 C](#fig4){ref-type="fig"}). Thus, our data are consistent with a 1NM-PP1--induced conformational change in the Ire1 variant itself, as proposed previously ([@bib23]).

![**Activation of Ire1 is not sufficient for RIDD.** (A) Percentage of spliced XBP-1 in the absence (gray bars) and presence (black bars) of 7 µM 1NM-PP1 in the indicated cell lines. Splicing was measured as in [Fig. 3 B](#fig3){ref-type="fig"}. (B) Relative RNA abundance of ERdj4, measured by qPCR, in the absence (gray bars) and presence (black bars) of 1NM-PP1. RNA abundance was normalized to that of Rpl19, and ERdj4/Rpl19 ratios for experimental samples were divided by those for untreated cells from the same experiment. (C) Western blot of hIre-I642G--Flag. GAPDH, glyceraldehyde 3-phosphate dehydrogenase. (D and E) Relative RNA abundance of two RIDD targets, Blos1 (D) and Scara3 (E), measured as in B. Gray bars, no 1NM-PP1; black bars, 7 µM 1NM-PP1. (F) Relative RNA abundance in *hIre1^R^-I642G* cells measured as in B. Control cells (shaded bars) and cells depleted of XBP-1 using RNAi (open bars) were treated with 1NM-PP1 only or 1NM-PP1 and DTT. (G and H) Percentage of spliced XBP-1 (G) and relative mRNA abundance for ERdj4 and Blos1 (H) in various concentrations of 1NM-PP1 and/or DTT. Measurements are as described for A and B. (A--H) Cells were treated with 2 mM DTT, 3 µg/ml Tm, and/or 7 µM 1NM-PP1 for 5 h unless otherwise indicated. The means and SD for three to five independent experiments are shown.](JCB_200903014_RGB_Fig4){#fig4}

In contrast to XBP-1 splicing and ERdj4 induction, no degradation of RIDD substrates was observed with 1NM-PP1 alone, indicating that XBP-1 splicing and RIDD are separable functions of Ire1 and have distinct requirements for activation ([Fig. 4, D and E](#fig4){ref-type="fig"}). Treatment of cells expressing Ire1-I642G with DTT or Tm alone (in the absence of 1NM-PP1) had very little effect on splicing or RIDD targets. However, cells treated with both 1NM-PP1 and ER stress degraded RIDD targets to similar levels as those expressing the wild-type Ire1 ([Fig. 4, D and E](#fig4){ref-type="fig"}). As a further control, we confirmed the XBP-1 independence of RIDD in these cells. XBP-1 is transcriptionally induced in our cells in a largely Ire1-independent manner and therefore does not occur to a significant extent in cells treated with 1NM-PP1 alone. Therefore, we depleted XBP-1 from cells expressing Ire1-I642G using RNAi, and although this blocked induction of ERdj4 by DTT, RIDD remained intact when cells were treated with both 1NM-PP1 and DTT ([Fig. 4 F](#fig4){ref-type="fig"}).

To determine whether the lack of RIDD in our 1NM-PP1--induced cells is merely a threshold effect, we treated cells with higher concentrations of 1NM-PP1, such that no further XBP-1 splicing or ERdj4 activation could be achieved with 1NM-PP1 alone ([Fig. 4, G and H](#fig4){ref-type="fig"}). The levels of XBP-1 splicing in cells expressing hIre1-I642G treated with 30 µM 1NM-PP1 were as high or higher than those seen in wild-type cells treated with low concentrations of DTT ([Fig. 4 G](#fig4){ref-type="fig"}) or with Tm ([Fig. 4 A](#fig4){ref-type="fig"}), where RIDD was clearly functioning. Note that although XBP-1 splicing appears insensitive to low concentrations of DTT in [Fig. 4 G](#fig4){ref-type="fig"}, we observed partial splicing shortly after the addition of DTT followed by rapid recovery before changes in gene expression could be reliably measured. For cells expressing wild-type hIre1, ERdj4 and RIDD appeared to be activated in parallel by low DTT concentrations, suggesting that RIDD is not limited to extreme ER stress ([Fig. 4 H](#fig4){ref-type="fig"}). In contrast to splicing and activation of ERdj4, no change in mRNA abundance for RIDD targets was detected in cells expressing hIre1-I642G and treated with 1NM-PP1 alone, even at high concentrations, although the cells were still capable of inducing RIDD when treated with 1NM-PP1 and DTT together ([Fig. 4 H](#fig4){ref-type="fig"}). In summary, although XBP-1 splicing and downstream transcriptional induction can be artificially induced with 1NM-PP1, RIDD cannot.

Implications for the mechanism of RIDD
--------------------------------------

Our results indicate that in mammalian cells, RIDD requires an active Ire1 nuclease domain but does not, per se, depend on Ire1\'s kinase activity. ER stress--dependent degradation of RNAs by hIre1-I642G was seen at concentrations of 1NM-PP1 ∼1.5-fold higher than those that inhibited the kinase activity of the protein in vitro ([@bib23]) and sixfold higher than those that inhibited kinase activity in HEK293 cells ([@bib20]). These data, together with the observation that RIDD does not require new transcription, are consistent with a direct mechanism of mRNA target cleavage by Ire1, although we cannot rule out an alternative role for Ire1\'s nuclease activity and/or the involvement of other nucleases.

However, our data also indicate that activation of Ire1\'s nuclease is not sufficient for RIDD. This observation represents a mechanistic divergence between RIDD and Ire\'s well-established role in XBP-1 splicing, which is induced by 1NM-PP1 activation of hIre1-I642G. There are several potential explanations for this. It may be that Ire1 assumes a distinct conformation or oligomerization state when activated by 1NM-PP1 versus ER stress and that although the former is sufficient for splicing XBP-1, the latter is required for RIDD. For example, it was recently found that yeast Ire1 forms higher order oligomers that lead to higher levels of RNase activity ([@bib1]; [@bib17]). Such oligomers may form only in the presence of misfolded proteins or, conversely, in the absence of binding to BiP, an ER chaperone which binds Ire1 and is titrated off by misfolded proteins during ER stress. A second possibility is that other factors activated by ER stress are necessary for RIDD. Although new transcription of such a factor is not required ([Fig. 2](#fig2){ref-type="fig"}), there may be proteins recruited or activated by ER stress that are important for mRNA decay but not for splicing. Finally, the complement of mRNAs available for targeting to this decay pathway may change upon subjecting cells to ER stress. Certain signal sequences are sensitive to the ER folding environment and influence how associated ribosomes partition between the ER and cytoplasm ([@bib16]); thus, a substantial change in the pool of mRNAs associated with the ER membrane under stress conditions could affect the RIDD pathway.

The fact that the two outputs of Ire1\'s nuclease activity, RIDD and XBP-1 splicing, can be differentially activated reveals an unanticipated complexity in the UPR. Growing evidence suggests that various sensors associated with the UPR are activated under different conditions, allowing for specific responses to different forms of ER stress in different cell types ([@bib7]; [@bib6]). This customization of responses may extend to activation within Ire1 itself. Activation of XBP-1 leads to a protective remodeling and expansion of the secretory pathway, whereas RIDD reduces the load of incoming proteins. Under certain physiological situations, e.g., during plasma cell development, activating the XBP-1--dependent remodeling pathway without inducing RIDD may be more beneficial; thus, cells may induce an active state of Ire1 that is similar to the 1NM-PP1--mediated activation described in this study. In contrast, conditions such as viral infection may call for a more destructive response that limits the load of incoming proteins, which is analogous to the effects of reduced translation mediated by the PERK (PKR-like ER kinase) branch of the UPR ([@bib10]). Intriguingly, both hepatitis C virus and human cytomegalovirus induce Ire1 but appear to block downstream effects of XBP-1 ([@bib27]; [@bib13]). However, hepatitis C virus protein production is increased in the absence of Ire1 ([@bib27]), suggesting that an alternate activity of Ire1 such as RIDD may be attenuating viral protein synthesis. It remains to be determined what role RIDD may play in viral infection and other physiological stress conditions, but the ability of this pathway to function in mammalian cells and the potential to decouple it from XBP-1 splicing could allow for a more specific and effective response to changing conditions within the ER.

Materials and methods
=====================

Establishment of Ire1-expressing cell lines and RNAi
----------------------------------------------------

*Ire1-α^−/−^* MEFs were obtained from R. Kaufman (University of Michigan Medical Center, Ann Arbor, MI), and *XBP1^−/−^* MEFs were obtained from L. Glimcher (Harvard School of Public Health, Boston, MA). All cells were maintained at 37°C and 5% CO~2~ in DME supplemented with 10% fetal calf serum, Gln, and antibiotics. We generated *Ire1-α^−/−^* MEFs containing ferritin-like protein recombination target (FRT) sites for site-specific transgene expression by transfection with pFRTlacZeo (Invitrogen), and stable clonal integrants were selected with Zeocin ([@bib5]). We then transfected the *Ire1-α^−/−^* FRT cells with the pOG44 ferritin-like protein recombinase vector (Invitrogen) and FRT vectors containing hIre1 under the control of the human ER-1α promoter ([@bib20]). QuikChange mutagenesis (Agilent Technologies) was used to make the point mutations in the hIre1 coding sequence. Multiple independent isogenic clones were analyzed for transgene mRNA and protein expression with identical findings. The ATP analogue 1NM-PP1 was a gift from C. Zhang and K. Shokat (University of California, San Francisco, San Francisco, CA; [@bib3]).

To deplete cells of Ire1 or XBP-1 by RNAi, we transfected ∼3 × 10^4^ cells with 150 ng total of a mixture of four different siRNAs (QIAGEN). After 48 h, we treated cells with DTT and/or 1NM-PP1, and purified RNA as described in the next section. We typically attained 90% knockdown as measured by qPCR.

Microarray experiments and analysis
-----------------------------------

We passaged and plated *Ire1^−/−^* and *hIre1^R^* cells into 150-cm^2^ flasks for collection of microarray samples. After a 3-d growth (at ∼70% confluency), we either left cells untreated or induced ER stress by adding 2 mM DTT for 6 h. We then harvested the cells and purified total RNA using TRIZOL (Invitrogen). To generate labeled samples for array hybridization, we amplified 0.5 µg RNA in a single round using the amino allyl MessageAmp II aRNA kit (Applied Biosystems). As a reference for the array hybridizations, we also amplified and labeled a pool of RNA samples from NIH-3T3, *Ire1^−/−^*, and *hIre1^R^* cells (both untreated and DTT treated). In parallel, we synthesized unlabeled cDNA from 2 µg of total RNA for qPCR measurements to confirm the array data. We repeated the entire experiment for a total of three times.

We hybridized 5 µg each of a Cy5-labeled experimental sample and the Cy3-labeled reference pool to whole-genome mouse arrays at 65°C for 48 h. The arrays were produced in-house using the MEEBOChip platform. We extracted and processed image data using GenePix 6 (MDS Analytical Technologies), normalized each array to achieve a mean Cy5/Cy3 ratio of 1.0, and removed spots containing low signal or poor signal uniformity. To simplify the analysis, we disregarded spots for which one or more samples did not pass these quality control measures and for which the SD of the three measurements was \>30% of the mean. For the remaining spots (representing ∼25% of the total spots on the array), we calculated the log~2~ ratio of DTT treated/untreated for each of the three replicates in the two cells lines. We then performed hierarchical clustering of the averaged data (Fig. S1).

To select robust RIDD candidates, we applied the following criteria to the 122 spots in clusters displaying Ire1-dependent down-regulation. First, we required the candidate RNA to be down-regulated by 1.5-fold (log~2~ \[DTT/untreated signal\] ≤ −0.58) in at least two of the three replicates and in the mean of the three replicates. Second, to select those RNAs whose down-regulation was truly Ire1 dependent, we required that the targets be down-regulated 1.5-fold more in the *hIre1^R^* cells compared with the *Ire1^−/−^* cells and display no more than a 25% decrease in signal in response to ER stress in the *Ire1^−/−^* cells. Lastly, to rule out artifacts caused by higher expression of the candidate RNAs in the *hIre1^R^* cells in the absence of ER stress, we also required that the mean signal intensity in the presence of ER stress was lower (by 15%) in the *hIre1^R^* cells compared with the *Ire1^−/−^* cells. 26 RIDD candidates fit these criteria; these are listed in [Table I](#tbl1){ref-type="table"}.

qPCR and XBP-1--splicing assays
-------------------------------

We purified RNA samples for all experiments using TRIZOL and synthesized cDNA from total RNA samples using Superscript II (Invitrogen). We then performed qPCR measurements using the primers shown in [Table S1](http://www.jcb.org/cgi/content/full/jcb.200903014/DC1). We measured each sample in triplicate using the Opticon (Bio-Rad Laboratories) or Realplex (Eppendorf) qPCR machines and normalized them using the signal from Rpl19, which did not change significantly relative to total RNA input concentration in any of the treatments used. We used mock cDNA samples containing no reverse transcription to ensure that the qPCR signals arose from cDNA and not from contaminating genomic DNA or other sources. To quantify the amount of XBP-1 splicing in each experiment, we amplified cDNA using primers surrounding the splice site (Table S1) and ran products on 2% agarose gels.

Western blotting
----------------

We washed cells in PBS and lysed them in radioimmunoprecipitation assay buffer (25 mM Tris, pH 7.6, 150 mM NaCl, 1% NP-40, 1% Na-deoxycholate, and 0.1% SDS) with added protease inhibitors. We resolved proteins on NuPage Bis-Tris 4--12% acrylamide gels (Invitrogen), transferred them to nitrocellulose membranes, and probed blots using primary polyclonal anti-Flag antibodies (Sigma-Aldrich) at a 1:2,000 dilution followed by secondary peroxidase-conjugated anti--rabbit antibodies (Jackson ImmunoResearch Laboratories) at a 1:5,000 dilution. As a loading control, we also probed blots with polyclonal anti-GAPDH (glyceraldehyde 3-phosphate dehydrogenase; ProSci, Inc.). We visualized the immunoblots using a chemiluminescent assay (ECL; GE Healthcare).

Online supplemental material
----------------------------

Fig. S1 shows the array data for *hIre1^−/−^* and *hIre1^R^* cell lines, a comparison with published data for UPR targets, and confirmation of RIDD target regulation measured by qPCR. Fig. S2 shows decay rate measurements for 11 RIDD candidates in the presence and absence of DTT. Table S1 displays the sequences for primers used in qPCR measurements. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/jcb.200903014/DC1>.
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**Note added in proof.** Ire1 but not Ire1-I642G activated by 1NM-PP1 was also recently found to degrade ER-localized mRNAs and promote apoptosis in INS-1 cells (Han et al. 2009. *Cell*. doi:[10.1016/j.cell.2009.07.017](10.1016/j.cell.2009.07.017)).

Abbreviations used in this paper: BiP, immunoglobin-binding protein; FRT, ferritin-like protein recombination target; hIre1, human Ire1-α; MEF, mouse embryonic fibroblast; qPCR, quantitative real-time PCR; RIDD, regulated Ire1-dependent decay; Tm, tunicamycin; UPR, unfolded protein response.
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